Paresh N. Soni
About
Paresh N. Soni is a scholar working on Nutrition and Dietetics, Surgery and Endocrinology, Diabetes and Metabolism.
According to data from OpenAlex, Paresh N. Soni has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Nutrition and Dietetics, 18 papers in Surgery and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Paresh N. Soni's work include Fatty Acid Research and Health (21 papers), Lipoproteins and Cardiovascular Health (13 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers). Paresh N. Soni is often cited by papers focused on Fatty Acid Research and Health (21 papers), Lipoproteins and Cardiovascular Health (13 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers). Paresh N. Soni collaborates with scholars based in United States, United Kingdom and Netherlands. Paresh N. Soni's co-authors include Rene A. Braeckman, Christie M. Ballantyne, Harold Bays, John J.P. Kastelein, William G. Stirtan, Jonathan L. Isaacsohn, Terry A. Jacobson, Jonathan D. Rowe, Sara B. Glickstein and Evan A. Stein and has published in prestigious journals such as The Lancet, Circulation and Hepatology.
In The Last Decade
Paresh N. Soni
39 papers receiving 1.5k citations
Peers
Paresh N. Soni
Fady Ntanios United States
Rebecca A. Juliano United States
Diane MacDougall United States
S. Balasubramaniam Australia
Franco Pazzucconi Italy
Piia Simonen Finland
C.J. Packard United Kingdom
Gabriele Bittolo Bon Italy
G. Kakis Canada
Sephy Philip United States
Citations per year, relative to Paresh N. Soni Paresh N. Soni (= 1×)
peers
Fady Ntanios
Countries citing papers authored by Paresh N. Soni
Since
Specialization
Citations
This map shows the geographic impact of Paresh N. Soni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paresh N. Soni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paresh N. Soni more than expected).
Fields of papers citing papers by Paresh N. Soni
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Paresh N. Soni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paresh N. Soni. The network helps show where Paresh N. Soni may publish in the future.
Co-authorship network of co-authors of Paresh N. Soni
This figure shows the co-authorship network connecting the top 25 collaborators of Paresh N. Soni. A scholar is included among the top collaborators of Paresh N. Soni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paresh N. Soni. Paresh N. Soni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Baumann, Ulrich, Ekkehard Sturm, Florence Lacaille, et al.. (2021). Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study. Clinics and Research in Hepatology and Gastroenterology. 45(5). 101751–101751.
2.
Ballantyne, Christie M., Harold Bays, Rene A. Braeckman, et al.. (2016). Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on plasma apolipoprotein C-III levels in patients from the MARINE and ANCHOR studies. Journal of clinical lipidology. 10(3). 635–645.e1.
3.
Bays, Harold, Christie M. Ballantyne, Rene A. Braeckman, et al.. (2015). Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester): Effects Upon High-Sensitivity C-Reactive Protein and Lipid Parameters in Patients With Metabolic Syndrome. Metabolic Syndrome and Related Disorders. 13(6). 239–247.
4.
Ballantyne, Christie M., Harold Bays, Rene A. Braeckman, et al.. (2015). Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester): Effects on Remnant-like Particle Cholesterol From the MARINE and ANCHOR Studies†. Journal of clinical lipidology. 9(3). 463–464.
5.
Braeckman, Rene A., William G. Stirtan, & Paresh N. Soni. (2014). Effect of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Omeprazole Plasma Pharmacokinetics in Healthy Adults. Drugs in R&D. 14(3). 159–164.
6.
Braeckman, Rene A., William G. Stirtan, & Paresh N. Soni. (2014). Effect of Concomitant Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on the Pharmacokinetics of Atorvastatin. Clinical Drug Investigation. 35(1). 45–51.
7.
Ballantyne, Christie M., Rene A. Braeckman, Harold Bays, et al.. (2014). Effects of icosapent ethyl on lipoprotein particle concentration and size in statin-treated patients with persistent high triglycerides (the ANCHOR Study). Journal of clinical lipidology. 9(3). 377–383.
8.
Braeckman, Rene A., William G. Stirtan, & Paresh N. Soni. (2014). Phase 1 Study of the Effect of Icosapent Ethyl on Warfarin Pharmacokinetic and Anticoagulation Parameters. Clinical Drug Investigation. 34(7). 449–456.
9.
Braeckman, Rene A., Mehar S. Manku, Harold Bays, William G. Stirtan, & Paresh N. Soni. (2013). Icosapent ethyl, a pure EPA omega-3 fatty acid: Effects on plasma and red blood cell fatty acids in patients with very high triglyceride levels (results from the MARINE study). Prostaglandins Leukotrienes and Essential Fatty Acids. 89(4). 195–201.
10.
Bays, Harold, Christie M. Ballantyne, Rene A. Braeckman, William G. Stirtan, & Paresh N. Soni. (2013). Icosapent Ethyl, a Pure Ethyl Ester of Eicosapentaenoic Acid: Effects on Circulating Markers of Inflammation from the MARINE and ANCHOR Studies. American Journal of Cardiovascular Drugs. 13(1). 37–46.
11.
Ballantyne, Christie M., Rene A. Braeckman, & Paresh N. Soni. (2013). Icosapent ethyl for the treatment of hypertriglyceridemia. Expert Opinion on Pharmacotherapy. 14(10). 1409–1416.
12.
Ballantyne, Christie M., Harold Bays, John J.P. Kastelein, et al.. (2012). Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study). The American Journal of Cardiology. 110(7). 984–992.
13.
Bays, Harold, Rene A. Braeckman, Christie M. Ballantyne, et al.. (2012). Icosapent ethyl, a pure EPA omega-3 fatty acid: Effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study). Journal of clinical lipidology. 6(6). 565–572.
14.
Jacobson, Terry A., Sara B. Glickstein, Jonathan D. Rowe, & Paresh N. Soni. (2012). Authors' reply to commentary entitled “EPA and DHA: Distinct yet essential n-3 fatty acids”. Journal of clinical lipidology. 6(5). 477–479.
15.
Ballantyne, Christie M., Harold Bays, John J.P. Kastelein, et al.. (2011). Abstract 15071: AMR101 Lowers Triglycerides, Atherogenic Lipoprotein, Phospholipase A2, and High-sensitivity C-reactive Protein Levels in Patients With High Triglycerides and on Background Statin Therapy (the ANCHOR Study). Circulation. 124.
16.
Bays, Harold, Christie M. Ballantyne, John J.P. Kastelein, et al.. (2011). Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial). The American Journal of Cardiology. 108(5). 682–690.
17.
Jacobson, Terry A., Sara B. Glickstein, Jonathan D. Rowe, & Paresh N. Soni. (2011). Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: A review. Journal of clinical lipidology. 6(1). 5–18.
18.
Soni, Paresh N., et al.. (1999). GB virus C/hepatitis G virus infection in KwaZulu Natal, South Africa. Journal of Medical Virology. 59(1). 38–44.
19.
Soni, Paresh N., et al.. (1998). Pneumonia and severe haemoptysis. The Lancet. 352(9123). 198–198.
20.
Khakoo, Salim I., et al.. (1996). ETIOLOGY, SCREENING, AND TREATMENT OF HEPATOCELLULAR CARCINOMA. Medical Clinics of North America. 80(5). 1121–1145.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Fady Ntanios Breakdown of academic impact, for papers by Rebecca A. Juliano Breakdown of academic impact, for papers by Diane MacDougall Breakdown of academic impact, for papers by S. Balasubramaniam Breakdown of academic impact, for papers by Franco Pazzucconi Breakdown of academic impact, for papers by Piia Simonen Breakdown of academic impact, for papers by C.J. Packard Breakdown of academic impact, for papers by Gabriele Bittolo Bon Breakdown of academic impact, for papers by G. Kakis Breakdown of academic impact, for papers by Sephy Philip